蒂螺医疗更换券商重启IPO辅导，董事长金义霖合计控股33%

Core Viewpoint - Shanghai Tiro Medical Co., Ltd. has completed its IPO counseling registration with the Shanghai Securities Regulatory Bureau, indicating its intention to go public [1][2]. Company Overview - Tiro Medical was established on July 3, 2017, with a registered capital of 44.266 million yuan [1]. - The company is a major domestic player in the research, design, and production of cosmetic contact lenses in China [1]. Shareholding Structure - The controlling shareholder, Jin Yilin, directly holds 33.21% of the shares and indirectly holds an additional 0.07% through Zhoushan Meimu Sutong Equity Investment Partnership (Limited Partnership), totaling 33.27% [2].